Stryker Corporation $SYK Shares Acquired by KPP Advisory Services LLC

KPP Advisory Services LLC increased its holdings in shares of Stryker Corporation (NYSE:SYK) by 17.2% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,318 shares of the medical technology company’s stock after purchasing an additional 193 shares during the period. KPP Advisory Services LLC’s holdings in Stryker were worth $521,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Goodman Advisory Group LLC acquired a new stake in Stryker in the first quarter valued at approximately $32,000. City Holding Co. boosted its stake in shares of Stryker by 528.6% in the first quarter. City Holding Co. now owns 88 shares of the medical technology company’s stock valued at $33,000 after purchasing an additional 74 shares during the period. Ridgewood Investments LLC grew its holdings in Stryker by 48.4% during the 2nd quarter. Ridgewood Investments LLC now owns 92 shares of the medical technology company’s stock valued at $36,000 after purchasing an additional 30 shares in the last quarter. Ransom Advisory Ltd purchased a new stake in Stryker during the 1st quarter worth $37,000. Finally, Smallwood Wealth Investment Management LLC acquired a new position in Stryker in the 1st quarter worth $40,000. Institutional investors and hedge funds own 77.09% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have recently issued reports on SYK. Rothschild Redb raised Stryker to a “hold” rating in a research report on Thursday, September 18th. Truist Financial set a $415.00 price target on shares of Stryker and gave the stock a “hold” rating in a research note on Monday, August 4th. Evercore ISI increased their price objective on shares of Stryker from $390.00 to $415.00 and gave the company an “outperform” rating in a research note on Tuesday, July 8th. BTIG Research reissued a “buy” rating on shares of Stryker in a report on Monday, July 14th. Finally, Rothschild & Co Redburn started coverage on shares of Stryker in a research report on Thursday, September 18th. They set a “neutral” rating and a $420.00 price target on the stock. Fifteen analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat.com, Stryker has an average rating of “Moderate Buy” and an average target price of $430.33.

Stryker Price Performance

Shares of NYSE:SYK opened at $370.59 on Monday. The company has a quick ratio of 1.06, a current ratio of 1.78 and a debt-to-equity ratio of 0.70. The firm has a 50-day simple moving average of $382.81 and a 200 day simple moving average of $378.96. Stryker Corporation has a fifty-two week low of $329.16 and a fifty-two week high of $406.19. The company has a market cap of $141.68 billion, a PE ratio of 49.08, a P/E/G ratio of 2.67 and a beta of 0.94.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.13 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.07 by $0.06. The company had revenue of $6.02 billion during the quarter, compared to the consensus estimate of $5.92 billion. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The company’s revenue for the quarter was up 11.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.81 earnings per share. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. On average, sell-side analysts anticipate that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be issued a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 30th. Stryker’s dividend payout ratio (DPR) is 44.50%.

Insider Transactions at Stryker

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of the business’s stock in a transaction dated Wednesday, August 6th. The shares were sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the sale, the director directly owned 3,222,108 shares in the company, valued at approximately $1,212,962,556.60. The trade was a 5.84% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Viju Menon sold 500 shares of the company’s stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $390.61, for a total transaction of $195,305.00. Following the completion of the sale, the insider directly owned 12,511 shares of the company’s stock, valued at approximately $4,886,921.71. This represents a 3.84% decrease in their ownership of the stock. The disclosure for this sale can be found here. 5.20% of the stock is owned by insiders.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.